Initial adjuvant weekly high dose methotrexate with leucovorin rescue in advanced squamous carcinoma of the head and neck (original) (raw)
Oral Methotrexate as Second Line Chemotherapy in Platinum-Refractory or Relapsed Squamous Cell Carcinoma of the Head and Neck
IRFAN HAIDER
Journal of Cancer & Allied Specialties
View PDFchevron_right
Sequential methotrexate–5-fluorouracil treatment of squamous cell carcinoma of the head and neck
Hans Strander
Cancer, 1983
View PDFchevron_right
Treatment of advanced squamous-cell carcinoma of the head and neck with alternating chemotherapy and radiotherapy
Frank Meyskens
American Journal of Otolaryngology, 1993
View PDFchevron_right
Preoperative combination chemotherapy for advanced stage head and neck cancer
Robert Ossoff
The American Journal of Surgery, 1984
View PDFchevron_right
Improved therapeutic index of methotrexate with "leucovorin rescue
Leonard Farber
Cancer research, 1973
View PDFchevron_right
Neoadjuvant chemotherapy in previously untreated patients with advanced head and neck squamous cell cancer
Diana Giannarelli
Cancer, 1988
View PDFchevron_right
Combined chemotherapy and radiation therapy in advanced inoperable squamous cell carcinoma of the head and neck. The final report of a randomized trial
Marco Merlano
Cancer, 1991
View PDFchevron_right
Adjuvant chemotherapy for resectable squamous cell carcinomas of the head and neck: Report of intergroup study 0034
David Schuller
International Journal of Radiation Oncology*Biology*Physics, 1992
View PDFchevron_right
Carboplatin, Continuous Infusion Fluorouracil and Mid-cycle High-dose Methotrexate as Initial Treatment in Patients with Locally Advanced Head and Neck Cancer
Kostas Sombolos
Tumori Journal, 1991
View PDFchevron_right
Combined modality treatment with full-dose chemotherapy and concomitant boost radiotherapy for advanced head and neck carcinoma
Mahmut Ozsahin
European Archives of Oto-Rhino-Laryngology, 2005
View PDFchevron_right
Intra-arterial methotrexate in head and neck tumors
james richard
European journal of cancer
View PDFchevron_right
Chemotherapy prior to local therapy in advanced squamous cell carcinoma of the head and neck. Preliminary assessment of an intensive drug regimen
tariq khan
Cancer, 1979
View PDFchevron_right
Messages from completed randomized trials in head and neck cancer
fausto chiesa
European Journal of Surgical Oncology (EJSO), 1997
View PDFchevron_right
A phase II trial of cisplatin, methotrexate, levofolinic acid, and 5‐fluorouracil in the treatment of patients with locally advanced, metastatic squamous cell carcinoma of the head and neck
M. Biglietto, Giacomo Carteni
Cancer, 1999
View PDFchevron_right
Chemotherapy alternated with radiotherapy in the treatment of advanced head and neck carcinoma: predictive factors of outcome
Vito Vitale
International Journal of Radiation Oncology*Biology*Physics, 1999
View PDFchevron_right
Chemotherapy in Head and Neck Cancer
Manuela Rosso
American Journal of Clinical Oncology, 2011
View PDFchevron_right
Effect of neoadjuvant single drug methotrexate therapy on tumor size reduction in oral squamous cell carcinoma: A pilot study
Seema Dengra
Indian Journal of Dentistry, 2013
View PDFchevron_right
Combined therapy in advanced head and neck cancers
Sudhir Bahadur
Journal of Laryngology and Otology, 1992
View PDFchevron_right
Chemo-Radiotherapeutic Management of Advanced Head and Neck Cancer
Luigi Pirtoli
Tumori Journal, 1989
View PDFchevron_right
Methotrexate and Leucovorin Double-modulated 5-Fluorouracil Combined with Cisplatin (MPFL) in Metastatic/Recurrent Head and Neck Cancer
peter m. chang
Journal of the Chinese Medical Association, 2008
View PDFchevron_right
Sequential chemotherapy and radiotherapy in advanced head and neck cancer
Patrick Bradley
Clinical Radiology, 1983
View PDFchevron_right
A randomized trial of neoadjuvant vs concomitant chemotherapy vs radiotherapy alone in the treatment of stage IV head and neck squamous cell carcinoma
Luiz Kowalski
European Archives of Oto-Rhino-Laryngology, 1992
View PDFchevron_right
Head and neck cancer emerging strategies: advances and new challenges
Gilberto Castro
Current Opinion in Oncology, 2009
View PDFchevron_right
Treatment of advanced head and neck cancer with concomitant radiation and chemotherapy
James Hutchinson
International Journal of Radiation Oncology Biology Physics, 1987
View PDFchevron_right
Methotrexate plus or minus cetuximab as first‐line treatment in a recurrent or metastatic (R/M) squamous cell carcinoma population of the head and neck (SCCHN), unfit for cisplatin combination treatment, a phase Ib‐randomized phase II study Commence
Esther Van Meerten
Head & Neck, 2020
View PDFchevron_right
Chemotherapy for head and neck cancer relapsing after radiotherapy
J. Sciubba
Cancer, 1981
View PDFchevron_right
Docetaxel, Cisplatin, Leucovorin and 5- Fluorouracil versus Leucovorin, 5-Fluorouracil, and Cisplatin as Neoadjuvant Chemotherapy Followed by Chemoradiation in Head and Neck Cancer
Akramul Islam
SAS journal of medicine, 2023
View PDFchevron_right
IMRT With Simultaneous Integrated Boost and Concurrent Chemotherapy for Locoregionally Advanced Squamous Cell Carcinoma of the Head and Neck
Tino Ceschia
International Journal of Radiation Oncology*Biology*Physics, 2011
View PDFchevron_right
Radiation with concurrent late chemotherapy intensification (‘chemoboost’) for locally advanced head and neck cancer
Andrew Sizeland
Radiotherapy and Oncology, 2000
View PDFchevron_right
Combined treatment of advanced head and neck cancer
igor fajdiga
International Congress Series, 2003
View PDFchevron_right
Adjuvant chemotherapy in advanced head and neck cancer☆An update
Rafael santos
American Journal of Surgery, 1982
View PDFchevron_right
Combination chemotherapy as induction therapy for advanced resectable head and neck cancer
Alan F Geater
Journal of Surgical Oncology, 2006
View PDFchevron_right
Postoperative Concurrent Radiotherapy and Chemotherapy for High-Risk Squamous-Cell Carcinoma of the Head and Neck
John Ensley
New England Journal of Medicine, 2004
View PDFchevron_right
Can concomitant-boost accelerated radiotherapy be adopted as routine treatment for head and neck cancers? A 10-year single institution experience
Pavel Dulguerov
View PDFchevron_right